Dermata Therapeutics Inc
NASDAQ:DRMA
Dermata Therapeutics Inc
NASDAQ:DRMA
Price:
1.2
USD
-0.83%
Market Closed
Market Cap:
$3.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Dermata Therapeutics Inc
NASDAQ:DRMA
|
US |
|
Totally PLC
LSE:TLY
|
UK |
|
J
|
Jiankun International Bhd
KLSE:JIANKUN
|
MY |
|
Orkla ASA
OTC:ORKLF
|
NO |
|
S
|
Shandong Newjf Technology Packaging Co Ltd
SZSE:301296
|
CN |
|
T
|
TScan Therapeutics Inc
NASDAQ:TCRX
|
US |
|
Apollo Global Management Inc
NYSE:APO
|
US |
|
V
|
Vodacom Group Ltd
JSE:VOD
|
ZA |
|
2
|
2G Energy AG
XETRA:2GB
|
DE |
|
Cambium Networks Corp
NASDAQ:CMBM
|
US |
|
Transcontinental Inc
TSX:TCL.A
|
CA |
|
Aquaporin A/S
CSE:AQP
|
DK |
|
F
|
Fujian Nanwang Environment Protection Scien-tech Co Ltd
SZSE:301355
|
CN |
|
Yara International ASA
OTC:YARIY
|
NO |
|
Alta Equipment Group Inc
NYSE:ALTG
|
US |
|
F
|
Finbond Group Ltd
JSE:FGL
|
ZA |
|
I
|
IN8BIO, Inc.
NASDAQ:INAB
|
US |
|
Nuvista Energy Ltd
TSX:NVA
|
CA |
|
McKay Securities PLC
LSE:MCKS
|
UK |
|
Dais Corp
OTC:DLYT
|
US |
|
Fsn E-Commerce Ventures Ltd
NSE:NYKAA
|
IN |
|
Syndax Pharmaceuticals Inc
NASDAQ:SNDX
|
US |
|
Alligator Bioscience AB
STO:ATORX
|
SE |
|
PJT Partners Inc
NYSE:PJT
|
US |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of DRMA.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
DRMA
Multiples-Based Value
Base Case
Not Available
Multiples Across Competitors
DRMA Competitors Multiples
Dermata Therapeutics Inc Competitors
Dermata Therapeutics Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Dermata Therapeutics Inc
NASDAQ:DRMA
|
3.4m USD | 0 | -0.4 | 0.1 | 0.1 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
901.8B USD | 13.8 | 43.7 | 29.5 | 31.4 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
587.8B USD | 6.2 | 21.9 | 15.2 | 18.7 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.4 | 11.5 | 13 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
233B GBP | 5.3 | 30.6 | 16.9 | 23.8 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
299B USD | 4.6 | 16.4 | 10.1 | 12.3 | |
| CH |
|
Novartis AG
SIX:NOVN
|
231.9B CHF | 5.4 | 21.7 | 13.4 | 17.3 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
162.3B USD | 2.6 | 20.9 | 7.9 | 10.6 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.4 | 10.3 | 7.6 | 8.9 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
124.3B USD | 2.6 | 17.6 | 7.4 | 9.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
